Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8198326 | 0.86 | MAPT (0.42) | RECQLMAPTKMT2AMEN1KDM4E | |
| SCHEMBL4655363 | 0.84 | RECQL (0.44) | RECQLMAPTKMT2AMEN1KDM4E | |
| Clothianidine SCHEMBL237824 | 0.84 | RECQL (0.39) | RECQLMAPTKMT2AMEN1KDM4E | |
| Clothianidine SCHEMBL14273626 | 0.84 | RECQL (0.39) | RECQLMAPTKMT2AMEN1KDM4E | |
| SCHEMBL4655361 | 0.84 | RECQL (0.44) | RECQLMAPTKMT2AMEN1KDM4E | |
| Clothianidine SCHEMBL21214 | 0.84 | RECQL (0.39) | RECQLMAPTKMT2AMEN1KDM4E | |
| Clothianidine SCHEMBL2413061 | 0.84 | RECQL (0.39) | RECQLMAPTKMT2AMEN1KDM4E | |
| SCHEMBL9843314 | 0.83 | MAPT (0.40) | RECQLMAPTKMT2AMEN1KDM4E | |
| SCHEMBL9728506 | 0.83 | MAPT (0.40) | RECQLMAPTKMT2AMEN1KDM4E | |
| SCHEMBL8801760 | 0.83 | L3MBTL1 (0.39) | RECQLMAPTKMT2AMEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841294-B2 | Active ingredient combinations having insecticidal and acaricidal properties | BAYER CROPSCIENCE AG (DE) | 2014-09-23 | — | — | US | disclosed |
| US-20130065761-A1 | Methods for Increasing the Resistance of Plants to Hypoxic Conditions | BAYER CROPSCIENCE N.V. (BE) | 2013-03-14 | — | — | US | disclosed |
| US-7659228-B2 | Synergistic insecticide mixtures | BAYER AKTIENGESELLSCHAFT (DE) | 2010-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065761-A1 | Methods for Increasing the Resistance of Plants to Hypoxic Conditions | COXFA4L2, HIF1A, HYOU1 | RECQL 1993/4885MAPT 4857/4885KMT2A 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.